Cefoparazone 1000 +Tazobaztum 125mg INJ

About Cefoparazone 1000 +Tazobaztum 125mg INJ

Cefoperazone 1000mg + Tazobactam 125mg Injection is a sterile powder for reconstitution, pairing the third-generation cephalosporin cefoperazone with beta-lactamase inhibitor tazobactam.
Cefoperazone inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, while tazobactam prevents beta-lactamase enzymes from degrading it, extending coverage against resistant Gram-positive, Gram-negative (including some Pseudomonas), and anaerobic bacteria.

Powerful Dual-Action Formula

Arkzone-T 1.125 harnesses the synergistic effect of cefoperazone and tazobactam. While cefoperazone disrupts bacterial cell wall synthesis, tazobactam inhibits enzymes that degrade antibiotics, allowing for enhanced activity against both Gram-positive and Gram-negative bacteria, including resistant species.


Indications for Use

This injection is indicated for treating moderate to severe infections such as intra-abdominal infections, skin and soft tissue infections, pneumonia, urinary tract infections, sepsis, and peritonitis. It is formulated to meet the demands of clinical and hospital-based therapy, ensuring broad-spectrum bacterial control.


Simple Storage and Preparation

Each Arkzone-T 1.125 vial contains sterile powder to be reconstituted before administration. For optimal efficacy and stability, keep the vial in a cool and dry place, and use within the 24-month shelf life. Follow healthcare provider instructions for reconstitution and administration.